The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Glioblastoma in the era of bevacizumab: An epidemiological study in the Canton of Zurich, Switzerland, 2010-2014.
 
Dorothee Gramatzki
No Relationships to Disclose
 
Patrick Roth
No Relationships to Disclose
 
Elisabeth Jane Rushing
No Relationships to Disclose
 
Jonathan Weller
No Relationships to Disclose
 
Nicolaus Andratschke
No Relationships to Disclose
 
Silvia Hofer
No Relationships to Disclose
 
Dimitri Korol
No Relationships to Disclose
 
Luca Regli
No Relationships to Disclose
 
Athina Pangalu
No Relationships to Disclose
 
Miklos Pless
No Relationships to Disclose
 
Joachim Oberle
No Relationships to Disclose
 
René Bernays
No Relationships to Disclose
 
Holger Moch
No Relationships to Disclose
 
Sabine Rohrmann
No Relationships to Disclose
 
Michael Weller
Honoraria - Lilly; Merck Serono; MSD; Novocure; Roche
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celldex; Lilly; Merck Serono; Pfizer; Roche; Teva
Research Funding - Acceleron Pharma (Inst); Actelion (Inst); Bayer (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Novocure (Inst); OGD2 Pharma (Inst); Piqur (Inst); Roche (Inst); Tragara (Inst)